These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 33710622)
1. Antibiotic therapy in sepsis: No next time for a second chance! Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622 [TBL] [Abstract][Full Text] [Related]
2. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock. Landersdorfer CB; Nation RL Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163 [TBL] [Abstract][Full Text] [Related]
3. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary? Blot S; Lipman J; Roberts DM; Roberts JA Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial. Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW; Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029 [TBL] [Abstract][Full Text] [Related]
5. [Adequate anti-infective treatment : Importance of individual dosing and application]. Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208 [TBL] [Abstract][Full Text] [Related]
6. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA; Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of β-lactam antibiotics in the ICU. Dhaese S; Van Vooren S; Boelens J; De Waele J Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263 [TBL] [Abstract][Full Text] [Related]
8. Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice? Scaglione F Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S40-2. PubMed ID: 26607342 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Roberts JA; Lipman J Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Varghese JM; Roberts JA; Lipman J Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of carbapenem antibiotics in critically ill patients: an overview of principles, recommended dosing regimens, and clinical outcomes. Joynt GM; Ling L; Wong WT; Lipman J Expert Rev Clin Pharmacol; 2023; 16(8):703-714. PubMed ID: 36942827 [TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy. Carrié C; Delzor F; Roure S; Dubuisson V; Petit L; Molimard M; Breilh D; Biais M Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964795 [TBL] [Abstract][Full Text] [Related]
16. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury. Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127 [TBL] [Abstract][Full Text] [Related]
17. Using PK/PD to optimize antibiotic dosing for critically ill patients. Roberts JA Curr Pharm Biotechnol; 2011 Dec; 12(12):2070-9. PubMed ID: 21554211 [TBL] [Abstract][Full Text] [Related]